View our free, on-demand webinar series to learn about the integrated Ion Torrent Genexus System

Part 1: Introducing the only true end-to-end NGS workflow

  • Discover how the Genexus System enables you to advance from biological specimen to report in as little as one day
  • Hear from two labs using the Genexus System and the Oncomine Precision Assay explain how and why they decided to use these solutions
  • Learn about the plan developed by Thermo Fisher Scientific for the IVDR transition

Speakers:

David Seidman, PhD, MB (ASCP) CM
Scientific Director for the Molecular Diagnostics and Serology Laboratories, Sentara Healthcare Laboratory Services, US
Philip Jermann, PhD
Head of Molecular Assay Development Unit Institute of Medical Genetics and Pathology, University Hospital Basel, Switzerland
Jon Sherlock, PhD
Director of Oncology Product Management, Thermo Fisher Scientific

Part 2: Sharing experiences from the world of easy NGS

  • Learn about the role the Genexus Integrated Sequencer has played in enabling laboratories around the world to provide fast genomic profiling services, even in times of crisis.
  • Hear from two European labs who implemented NGS for the first time with the Genexus System and the Oncomine Precision Assay

Speakers:

Annarita Destro, PhD
Senior Molecular Biologist, Medical Genetics, Humanitas Research Hospital, Italy
Réiltín Werner, MSc
Chief Medical Scientist, Molecular Pathology Laboratory, Cork University Hospital, Ireland

Part 3: Introducing a New World of NGS: A One-Day, Hands-Off Solution to Fit in any Lab

  • How the Ion Torrent Genexus System is addressing key challenges to next-generation sequencing (NGS) implementation, like hands-on time, time-to-result, user expertise, and affordability
  • Why, in combination with the Oncomine Precision Assay, the Genexus System represents a new-generation solution for genomic profiling of cancer samples
  • Thoughts from the first-ever laboratory to implement this solution: IPATIMUB in Portugal

Speakers:

José Luis Costa, PhD
Principal Researcher, IPATIMUP
Andy Felton, PhD
Vice President of Marketing and Product Management, Clinical Next Generation Sequencing, Thermo Fisher Scientific

Part 4: A New World of NGS. A New Day for Your Lab.

  • Understand how the Genexus System enables a broad spectrum of labs, even without previous expertise, to provide fast genomic profiling
  • See the future Genexus System assays pipeline
  • Hear from Sentara Molecular Pathology Laboratory about their experience with the Genexus System

Speakers:

Tabetha Sundin
Scientific Director, Molecular Diagnostics and Serology, Sentara Healthcare, Norfolk, Virginia
Andy Felton, PhD
Vice President of Marketing and Product Management, Clinical Next Generation Sequencing, Thermo Fisher Scientific
Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Part 5: Hear Both Sides of the Fusion Detection Story

  • Discuss the importance of detecting both novel fusions and known driver genes and partners
  • Review three different methods of fusion detection in a comparison study performed and presented by Dr. Wei Song
  • Hear about principle data generated by a FusionSync method developed by Dr. Philip Jermann

Speakers:

Dr. Wei Song, MD, PhD
Director of the Clinical Genomic Laboratory, Englander Institute for Precision Medicine
Assistant Professor of Pathology and Laboratory Medicine, Weill Cornell Medical College
Assistant Attending Pathologist, NewYork-Presbyterian Hospital
Dr. Philip Jermann, PhD
Head of Molecular Assay Development Unit Institute of Medical Genetics and Pathology, University Hospital Basel, Switzerland


Fill in the form to view the free on-demand webinar series.

(*Indicates a mandatory field)